These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

773 related items for PubMed ID: 17308858

  • 1. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
    Ye S, Chen XX, Lu XY, Wu MF, Deng Y, Huang WQ, Guo Q, Yang CD, Gu YY, Bao CD, Chen SL.
    Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
    [Abstract] [Full Text] [Related]

  • 2. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
    Fujisawa T, Hozumi H, Kono M, Enomoto N, Nakamura Y, Inui N, Nakashima R, Imura Y, Mimori T, Suda T.
    Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
    [Abstract] [Full Text] [Related]

  • 3. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
    Ikeda S, Arita M, Misaki K, Mishima S, Takaiwa T, Nishiyama A, Ito A, Furuta K, Yokoyama T, Tokioka F, Noyama M, Yoshioka H, Ishida T.
    Springerplus; 2015 Mar; 4():240. PubMed ID: 26101728
    [Abstract] [Full Text] [Related]

  • 4. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.
    Mukae H, Ishimoto H, Sakamoto N, Hara S, Kakugawa T, Nakayama S, Ishimatsu Y, Kawakami A, Eguchi K, Kohno S.
    Chest; 2009 Nov; 136(5):1341-1347. PubMed ID: 19581351
    [Abstract] [Full Text] [Related]

  • 5. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.
    J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718
    [Abstract] [Full Text] [Related]

  • 6. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
    Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R.
    Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors for myositis-associated interstitial lung disease.
    Fujisawa T, Hozumi H, Kono M, Enomoto N, Hashimoto D, Nakamura Y, Inui N, Yokomura K, Koshimizu N, Toyoshima M, Shirai T, Yasuda K, Hayakawa H, Suda T.
    PLoS One; 2014 May; 9(6):e98824. PubMed ID: 24905449
    [Abstract] [Full Text] [Related]

  • 8. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
    Wang PZ, Guan JL, Han XH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients.
    Peng JM, Du B, Wang Q, Weng L, Hu XY, Wu CY, Shi Y.
    PLoS One; 2016 Jun; 11(4):e0154441. PubMed ID: 27115138
    [Abstract] [Full Text] [Related]

  • 11. Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study.
    Ji Q, Pan W, Zhang D, Hou Y, Wang Z.
    Front Immunol; 2023 Jun; 14():1237209. PubMed ID: 38098481
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The prognostic value of HRCT in myositis-associated interstitial lung disease.
    Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Aihara K, Ikezoe K, Watanabe K, Taguchi Y, Hatta K, Oga T, Chin K, Nagai S, Mimori T, Mishima M.
    Respir Med; 2013 May; 107(5):745-52. PubMed ID: 23485097
    [Abstract] [Full Text] [Related]

  • 16. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF.
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
    Kurita T, Yasuda S, Amengual O, Atsumi T.
    Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
    [Abstract] [Full Text] [Related]

  • 18. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.
    Chen Z, Cao M, Plana MN, Liang J, Cai H, Kuwana M, Sun L.
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1316-24. PubMed ID: 23908005
    [Abstract] [Full Text] [Related]

  • 19. COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report.
    Cao M, Zhang S, Chu D, Xiao M, Liu X, Yu L, Li J, Huang Y, Fang F.
    BMC Pulm Med; 2020 Nov 19; 20(1):304. PubMed ID: 33213393
    [Abstract] [Full Text] [Related]

  • 20. Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease.
    Johnson C, Pinal-Fernandez I, Parikh R, Paik J, Albayda J, Mammen AL, Christopher-Stine L, Danoff S.
    Lung; 2016 Oct 19; 194(5):733-7. PubMed ID: 27166633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.